Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00206414
What this trial is testing

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer

Who this might be right for
BREAST CANCER
Baylor Breast Care Center 15
Testing effectiveness (Phase 2)Study completedNCT00057941
What this trial is testing

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast CancerRecurrent Breast Cancer+1 more
National Cancer Institute (NCI) 148
Early research (Phase 1)Study completedNCT00681967
What this trial is testing

Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer

Who this might be right for
Head and Neck Cancer
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT00100945
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 70
Testing effectiveness (Phase 2)Ended earlyNCT00082667
What this trial is testing

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 1
Early research (Phase 1)Study completedNCT02088112
What this trial is testing

MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).

Who this might be right for
Carcinoma, Non-Small-Cell Lung
MedImmune LLC 56
Testing effectiveness (Phase 2)Study completedNCT00522145
What this trial is testing

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Kadmon Corporation, LLC 41
Testing effectiveness (Phase 2)UnknownNCT03341494
What this trial is testing

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Who this might be right for
NSCLC Stage IVChemotherapy Effect
Fujian Cancer Hospital 128
Early research (Phase 1)Study completedNCT00502060
What this trial is testing

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

Who this might be right for
Advanced Tumor
AstraZeneca 65
Testing effectiveness (Phase 2)Ended earlyNCT01871480
What this trial is testing

CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Kunming Medical University 50
Large-scale testing (Phase 3)Study completedNCT00144066
What this trial is testing

Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
West Japan Thoracic Oncology Group 600
Large-scale testing (Phase 3)Study completedNCT00807066
What this trial is testing

Randomized Gefitinib Trial

Who this might be right for
Non Small Cell Lung Cancer
Fondazione Humanitas per la Ricerca 1
Testing effectiveness (Phase 2)Study completedNCT01933347
What this trial is testing

Third-line Treatment of Gefitinib in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials 46
Early research (Phase 1)Study completedNCT00328562
What this trial is testing

ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 13
Large-scale testing (Phase 3)Study completedNCT00259064
What this trial is testing

Iressa v BSC (Best Supportive Care) in First Line NSCLC

Who this might be right for
NSCLC
AstraZeneca 216
Testing effectiveness (Phase 2)UnknownNCT01502202
What this trial is testing

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Who this might be right for
Non Small Cell Lung CancerAdenocarcinoma
National Cancer Center, Korea 162
Testing effectiveness (Phase 2)Study completedNCT00409006
What this trial is testing

Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 70
Testing effectiveness (Phase 2)Study completedNCT00066378
What this trial is testing

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 71
Large-scale testing (Phase 3)UnknownNCT03656393
What this trial is testing

To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma

Who this might be right for
NSCLCEGFR
Shenzhen People's Hospital 48
Early research (Phase 1)Study completedNCT00185835
What this trial is testing

Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck CancerCarcinoma, Squamous Cell
Stanford University 10
Next Page